Glenmarks Ryaltris®- innovative single nasal spray, ready to market in Russia MUMBAI, India, Feb. 22, 2021 /PRNewswire/ -- Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty S A, received marketing approval from the Ministry of Health of the Russian Federation for its innovative Ryaltris® Nasal Spray - a novel fixed-dose combination nasal spray. This paves the way for commercialization of Ryaltris® in Russia which is expected to be made available to patients in the country in...